|
Resistance trend in isolates of Streptococcus pneumoniae over a 5-year period in Kuwait |
|||||
| Antibiotics |
Percentage (%) of resistant isolates in: |
||||
|
|
|||||
| 1999 (n = 78) |
2000 (n = 61) |
2001 (n = 73) |
2002 (n = 66) |
2003 (n = 90) |
|
|
|
|||||
| Cefotaxime |
0 |
0 |
4 |
5 |
6 |
| Ceftriaxone |
0 |
0 |
3 |
5 |
4 |
| Cefuroxime |
0 |
0 |
8 |
9 |
41 |
| Cephalexin |
0 |
0 |
NT |
NT |
NT |
| Chloramphenicol |
3 |
5 |
25 |
5 |
0 |
| Erythromycin |
16 |
20 |
23 |
26 |
30 |
| Imipenem |
0 |
0 |
0 |
0 |
0 |
| Penicillin |
32 |
38 |
46 |
52 |
54 |
| Teicoplanin |
0 |
0 |
0 |
0 |
0 |
| Vancomycin |
0 |
0 |
0 |
0 |
0 |
|
NT = not tested | |||||
Zhang et al. Globalization and Health 2006 2:6 doi:10.1186/1744-8603-2-6 |
|||||